Inverted-U–shaped dopamine actions on human working memory and cognitive control R Cools, M D'Esposito Biological psychiatry 69 (12), e113-e125, 2011 | 1688 | 2011 |
Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands R Cools, RA Barker, BJ Sahakian, TW Robbins Cerebral cortex 11 (12), 1136-1143, 2001 | 1120 | 2001 |
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease R Cools Neuroscience & Biobehavioral Reviews 30 (1), 1-23, 2006 | 1088 | 2006 |
Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging R Cools, L Clark, AM Owen, TW Robbins Journal of Neuroscience 22 (11), 4563-4567, 2002 | 942 | 2002 |
Serotoninergic regulation of emotional and behavioural control processes R Cools, AC Roberts, TW Robbins Trends in cognitive sciences 12 (1), 31-40, 2008 | 722 | 2008 |
L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease R Cools, RA Barker, BJ Sahakian, TW Robbins Neuropsychologia 41 (11), 1431-1441, 2003 | 666 | 2003 |
The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning L Clark, R Cools, TW Robbins Brain and cognition 55 (1), 41-53, 2004 | 612 | 2004 |
Mechanisms of cognitive set flexibility in Parkinson's disease R Cools, RA Barker, BJ Sahakian, TW Robbins Brain 124 (12), 2503-2512, 2001 | 511 | 2001 |
Dopaminergic modulation of high‐level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET R Cools, E Stefanova, RA Barker, TW Robbins, AM Owen Brain 125 (3), 584-594, 2002 | 504 | 2002 |
Serotonin and dopamine: unifying affective, activational, and decision functions R Cools, K Nakamura, ND Daw Neuropsychopharmacology 36 (1), 98-113, 2011 | 497 | 2011 |
Mechanisms of motivation–cognition interaction: challenges and opportunities TS Braver, MK Krug, KS Chiew, W Kool, JA Westbrook, NJ Clement, ... Cognitive, affective, & behavioral neuroscience 14, 443-472, 2014 | 489 | 2014 |
Role of dopamine in the motivational and cognitive control of behavior R Cools The Neuroscientist 14 (4), 381-395, 2008 | 453 | 2008 |
Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration R Cools, MJ Frank, SE Gibbs, A Miyakawa, W Jagust, M D'Esposito Journal of Neuroscience 29 (5), 1538-1543, 2009 | 406 | 2009 |
Disentangling the roles of approach, activation and valence in instrumental and pavlovian responding QJM Huys, R Cools, M Gölzer, E Friedel, A Heinz, RJ Dolan, P Dayan PLoS computational biology 7 (4), e1002028, 2011 | 395 | 2011 |
Reversal learning in Parkinson's disease depends on medication status and outcome valence R Cools, L Altamirano, M D’Esposito Neuropsychologia 44 (10), 1663-1673, 2006 | 360 | 2006 |
L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease R Cools, SJG Lewis, L Clark, RA Barker, TW Robbins Neuropsychopharmacology 32 (1), 180-189, 2007 | 346 | 2007 |
Working memory capacity predicts dopamine synthesis capacity in the human striatum R Cools, SE Gibbs, A Miyakawa, W Jagust, M D'Esposito Journal of Neuroscience 28 (5), 1208-1212, 2008 | 344 | 2008 |
Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory R Cools, M Sheridan, E Jacobs, M D'Esposito Journal of Neuroscience 27 (20), 5506-5514, 2007 | 319 | 2007 |
Chemistry of the adaptive mind R Cools, TW Robbins Philosophical Transactions of the Royal Society of London. Series A …, 2004 | 301 | 2004 |
Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective TW Robbins, R Cools Movement Disorders 29 (5), 597-607, 2014 | 286 | 2014 |